MALVERN, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the ...
MALVERN, Pa., March 01, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ...
MALVERN, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve ...
NeuroStar, developed by Neuronetics, Inc., is the first transcranial magnetic stimulation (TMS) device to receive Breakthrough Device Designation for bipolar depression MALVERN, Pa., March 06, 2020 ...
MALVERN, Pa., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. STIM, a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results